Investment & deals

  • SheMed raises €43m to scale UK operations

    London-based women’s health platform SheMed has raised €43m to expand its UK operations and further develop its personalised healthcare platform. The company, founded by sisters Olivia and Chloe Ferro in April 2024, will use the investment to scale its medical and technology teams, strengthen clinical infrastructure and enhance its data-driven systems. SheMed offers weight management [...]

  • Editor’s comment: Women’s health investment surges – but is it enough?

    There’s a sense of momentum in women’s health right now. In the span of just weeks, major new funds have been announced, mobilising hundreds of millions of dollars for maternal health, reproductive rights, and research into conditions that disproportionately affect women. It feels like the shift the sector has been waiting for, but the real [...]

  • Spinout awarded £1.75m for AI-powered fetal ultrasound trial

    Fraiya Ltd has secured £1.75m to test how artificial intelligence could improve fetal ultrasound screening across several NHS sites. The National Institute for Health and Care Research (NIHR) grant will support a 27-month trial of AI-assisted anomaly detection in pregnancy scans. If successful, the tool could be integrated into NHS services and shape national standards [...]

  • UCL spin-out raises £2.5m to improve infant health with breast milk microbiome

    London-based biotechnology company BoobyBiome has raised £2.5m in seed funding for its infant feeding solutions. The funding round was led by specialist deep tech investor Empirical Ventures, alongside The Helm, XFactor Ventures, Lavender Ventures, Kayan Ventures, and Evenlode Investment, with influential angels including Dominic Hollamby, Lord Ara Darzi, Yael Cohen, Vanessa Colomar, and others. Founded [...]

  • Round up: £1m for women’s health research and care

    Femtech World explores the latest business developments in women’s health. Portfolia launches women's health fund Investing fund Portfolia has launched the Women's Health Fund IV for women's health innovation. The company has stated that Fund IV's debut investment is in Gameto, a clinical-stage biotechnology company reprogramming female cells to transform fertility and hormonal care. [...]

  • MIT initiative will ‘give women’s health the attention it deserves’

    A new US$10m fund will back research into how the uterus affects immune function and why women face higher risks of chronic disease. The Fairbairn Menstruation Science Fund, launched by the MIT Health and Life Sciences Collaborative (MIT HEALS), is supported by a donation from philanthropists Emily and Malcolm Fairbairn. It will explore links between [...]

  • Trust awarded £250,000 government funding to launch pioneering endometriosis trial

    University Hospitals of North Midlands (UHNM) has secured £250k to trial a dye-based technique in endometriosis surgery aimed at reducing pain and surgical complications. The two-year ICE trial will compare the use of indocyanine green (ICG) dye with standard ureter stenting, aiming to better protect urinary structures during deep endometriosis procedures. Funded by the NIHR [...]

  • Eight startups join brain health accelerator

    Eight tech startups have joined an accelerator programme developing tools to tackle women's cardiovascular and brain health conditions. The firms have been selected for the American Heart Association Heart and Brain Health Accelerator, which offers mentoring, funding opportunities and industry connections to healthcare startups. The accelerator is run through a collaboration between American Heart Association [...]

  • Talkspace and Tia partner on women’s mental health

    Talkspace has partnered with women’s healthcare provider Tia to integrate mental health services into primary care across all stages of a woman’s life. The agreement will see Tia’s clinicians refer patients to Talkspace for therapy and psychiatric care, creating what the companies describe as a comprehensive model that addresses both physical and mental health. The [...]

  • Escala Medical raises US$4.5m for prolapse device

    Escala Medical has secured US$4.5m in Series A funding to expand use of its FDA-cleared device for pelvic organ prolapse, bringing total funding to over US$8m. Proceeds from the funding round will support commercial expansion in the US, market entry in Europe following anticipated CE mark approval in 2026, and rollout in Southeast Asia via [...]